SCHEMBL5364253

SCHEMBL5364253

CCOC(=O)c1cc(O)c(F)c(F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.58
CA1 P00915 3/20 0.58
CA2 P00918 3/20 0.58
CA7 P43166 3/20 0.58
CA9 Q16790 3/20 0.58
CA14 Q9ULX7 3/20 0.58
PTPN11 Q06124 2/20 0.56
SERPINE1 P05121 4/20 0.50
ESR1 P03372 3/20 0.50
ESR2 Q92731 1/20 0.49
HSD17B2 P37059 1/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
AKR1C1 Q04828 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
BCL2L1 Q07817 1/20 0.47
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16055405 0.91 CA12 (0.63) CA12CA1CA2CA7CA9
SCHEMBL1999331 0.89 CA12 (0.60) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL39599 0.83 SERPINE1 (0.70) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL27840060 0.82 SERPINE1 (0.68) CA12CA1CA2CA7CA9
SCHEMBL23883091 0.81 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL21189808 0.81 SERPINE1 (0.50) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL29200753 0.80 SERPINE1 (0.66) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL29200784 0.80 SERPINE1 (0.66) CA12CA1CA2CA7CA9
SCHEMBL24075195 0.80 CA12 (0.54) CA12CA1CA2CA7CA9
SCHEMBL13266684 0.80 CA12 (0.68) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205409-B2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBOTT LABORATORIES (US) 2007-04-17 US disclosed
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) ABBVIE INC. 2005-06-16 US disclosed
WO-2005023762-A1 PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBOTT LABORATORIES (US) 2005-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050131019-A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) DPP4, DPP3, DPP7 CA12 2859/4885CA1 2745/4885CA2 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.